HIV Citations List: January, 2016

Literature Citations

1. One-pot Synthesis of N-Aryl 1,4-dihydropyridine Derivatives and their Biological Activities. Dhinakaran, I., V. Padmini, and N. Bhuvanesh. Journal of Chemical Sciences, 2015. 127(12): p. 2201-2209. ISI[000367540300010].

[WOS]. HIV_01_2016.

2. In vitro anti-HIV-1 Activity of Fucoidan from Sargassum swartzii. Dinesh, S., T. Menon, L.E. Hanna, V. Suresh, M. Sathuvan, and M. Manikannan. International Journal of Biological Macromolecules, 2016. 82: p. 83-88. PMID[26472515].

[PubMed]. HIV_01_2016.

3. Facile Synthesis of the NNRTI Microbicide MC-1220 and Synthesis of Its Phosphoramidate Prodrugs. Loksha, Y.M., E.B. Pedersen, P. La Colla, and R. Loddo. Organic & Biomolecular Chemistry, 2016. 14(3): p. 940-946. PMID[26608715].

[PubMed]. HIV_01_2016.

4. Soybean-derived Bowman-Birk Inhibitor (BBI) Inhibits HIV Infection of Human Macrophages. Ma, T.C., X. Wang, J.L. Li, L. Zhou, K. Zhuang, J.B. Liu, Y. Zhou, and W.Z. Ho. Journal of Neuroimmune Pharmacology, 2015. 10: p. S84-S85. ISI[000367554100074].

[WOS]. HIV_01_2016.

5. Specific Inhibitors of HIV Capsid Assembly Binding to the C-terminal Domain of the Capsid Protein: Evaluation of 2-Arylquinazolines as Potential Antiviral Compounds. Machara, A., V. Lux, M. Kozisek, K. Grantz Saskova, O. Stepanek, M. Kotora, K. Parkan, M. Pavova, B. Glass, P. Sehr, J. Lewis, B. Muller, H.G. Krausslich, and J. Konvalinka. Journal of Medicinal Chemistry, 2016. 59(2): p. 545-558. PMID[26685880].

[PubMed]. HIV_01_2016.

6. Synthesis and Evaluation of 3-Hydroxy-3-phenylpropanoate ester-AZT Conjugates as Potential Dual-action HIV-1 Integrase and Reverse Transcriptase Inhibitors. Manyeruke, M.H., T.O. Olomola, S. Majumder, S. Abrahams, M. Isaacs, N. Mautsa, S. Mosebi, D. Mnkandhla, R. Hewer, H.C. Hoppe, R. Klein, and P.T. Kaye. Bioorganic & Medicinal Chemistry, 2015. 23(24): p. 7521-7528. PMID[26775541].

[PubMed]. HIV_01_2016.

7. Anti-HIV Activity of Hyptis Jacq. (Lamiaceae). Partida, M.D.S., K.P. Santos, B. Loureiro, and C.M. Furlan. Planta Medica, 2015. 81(16): p. 1448-1448. ISI[000367558100190].

[WOS]. HIV_01_2016.

8. Influence of Structural Parameters on the Self-association Properties of anti-HIV Catanionic Dendrimers. Perez-Anes, A., F. Rodrigues, A.M. Caminade, C. Stefaniu, B. Tiersch, C.O. Turrin, and M. Blanzat. ChemPhysChem, 2015. 16(16): p. 3433-3437. PMID[26377841].

[PubMed]. HIV_01_2016.

9. Nitrogen Positional Scanning in Tetramines Active against HIV-1 as Potential CXCR4 Inhibitors. Puig de la Bellacasa, R., A. Gibert, J.M. Planesas, L. Ros-Blanco, X. Batllori, R. Badia, B. Clotet, J. Este, J. Teixido, and J.I. Borrell. Organic & Biomolecular Chemistry, 2016. 14(4): p. 1455-1472. PMID[26691389].

[PubMed]. HIV_01_2016.

10. Anti-HIV-1 Integrase Diterpenoids from Dichrocephala benthamii. Song, B., G. Ding, X.H. Tian, L. Li, C. Zhou, Q.B. Zhang, M.H. Wang, T. Zhang, and Z.M. Zou. Phytochemistry Letters, 2015. 14: p. 249-253. ISI[000366569300044].

[WOS]. HIV_01_2016.

11. Fullerene-based Inhibitors of HIV-1 Protease. Strom, T.A., S. Durdagi, S.S. Ersoz, R.E. Salmas, C.T. Supuran, and A.R. Barron. Journal of Peptide Science, 2015. 21(12): p. 862-870. PMID[26767741].

[PubMed]. HIV_01_2016.

12. Design, Synthesis and Activity Evaluation of Novel Peptide Fusion Inhibitors Targeting HIV-1 gp41. Tan, J., M. Su, Y. Zeng, and C. Wang. Bioorganic & Medicinal Chemistry, 2016. 24(2): p. 201-206. PMID[26706116].

[PubMed]. HIV_01_2016.

13. A Stereo Configuration-activity Study of 3-Iodo-4-(2-methylcyclohexyloxy)-6-phenethylpyridin-2(2H)-ones as Potency Inhibitors of HIV-1 Variants. Wu, S., Q. Yin, L. Zhao, N. Fan, X. Tang, J. Zhao, T. Sheng, Y. Guo, C. Tian, Z. Zhang, W. Xu, Z. Liu, S. Jiang, L. Ma, J. Liu, and X. Wang. Organic & Biomolecular Chemistry, 2016. 14(4): p. 1413-1420. PMID[26676723].

[PubMed]. HIV_01_2016.

14. New Securinega Alkaloids with anti-HIV Activity from Flueggea virosa. Zhang, H., C.R. Zhang, Y.S. Han, M.A. Wainberg, and J.M. Yue. RSC Advances, 2015. 5(129): p. 107045-107053. ISI[000367274300082].

[WOS]. HIV_01_2016.

15. Aspernigrins with anti-HIV-1 Activities from the Marine-derived Fungus Aspergillus niger SCSIO Jcsw6F30. Zhou, X., W. Fang, S. Tan, X. Lin, T. Xun, B. Yang, S. Liu, and Y. Liu. Bioorganic & Medicinal Chemistry Letters, 2016. 26(2): p. 361-365. PMID[26711143].

[PubMed]. HIV_01_2016.

Patent Citations

16. A Quinoline Derivative for the Treatment of Inflammatory Diseases and AIDS. Patent. 2016. 2014-306166 2975034: 18pp.

[Patent]. HIV_01_2016.

17. Novel Betulinic Proline Imidazole Derivatives as HIV Inhibitors. Bandi, P.R., R.R. Kura, P.R. Adulla, D.K. Gazula Levi, E.R. Bammidi, and R.R. Kothakapu. Patent. 2016. 2015-IB54864 2016001820: 78pp.

[Patent]. HIV_01_2016.

18. Modulators of Toll-like Receptors for the Treatment of Human Immunodeficiency Virus (HIV) Infection. Geleziunas, R. and J.E. Hesselgesser. Patent. 2016. 2015-US39776 2016007765: 308pp.

[Patent]. HIV_01_2016.

19. Phenyl and Tertbutylacetic acid Substituted Pyridinones Having anti-HIV Effects. Johns, B.A. and E.J. Velthuisen. Patent. 2016. 2015-IB55385 2016012913: 35pp.

[Patent]. HIV_01_2016.

20. Preparation of Isoindoline Derivatives for Use in the Treatment of a Viral Infection. Johns, B.A., E.J. Velthuisen, J.G. Weatherhead, L. Suwandi, and D. Temelkoff. Patent. 2016. 2015-IB55095 2016005878: 227pp.

[Patent]. HIV_01_2016.